Maison Luxe, Inc. (MASN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -298.82 Thousand | -508.95 Thousand | -2.26 Million | -171.04 Thousand | -72 Thousand | -548.79 Thousand |
| Net Income | 1.67 Million | -6.66 Million | -2.3 Million | -3.22 Million | -244.53 Thousand | -972.54 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 4.26 Million | 270.89 Thousand | - | 100 Thousand | 435 Thousand |
| Change in working capital | 715.42 Thousand | 1.74 Million | -703.87 Thousand | 276.52 Thousand | - | -18.22 Thousand |
| Other non-cash items | -3.36 Million | 2.63 Million | 1.43 Million | 2.5 Million | 72.53 Thousand | 460.2 Thousand |
| Investing Cash Flow | 200 Thousand | -135 Thousand | 55 Thousand | -300 Thousand | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -270 Thousand | -515 Thousand | -300 Thousand | - | - |
| Sales/Maturities of investments | - | 135 Thousand | 570 Thousand | - | - | - |
| Other Investing Activities | 200 Thousand | -135 Thousand | 55 Thousand | -300 Thousand | - | - |
| Financing Cash Flow | 32.39 Thousand | 364 Thousand | 2.19 Million | 500 Thousand | 72 Thousand | 546.8 Thousand |
| Debt repayment | -63 Thousand | -6000.00 | -1.45 Million | - | -27 Thousand | -161 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 95.4 Thousand | 370 Thousand | 525.75 Thousand | 500 Thousand | 45 Thousand | 185.8 Thousand |
| Other Financing Activities | - | 364 Thousand | 221.77 Thousand | 727.57 Thousand | 72 Thousand | 200 Thousand |
| Accounts receivables | 374.77 Thousand | -390.4 Thousand | 153.88 Thousand | -230 Thousand | - | - |
| Accounts payables | -60.65 Thousand | 374.39 Thousand | 1.07 Million | -1.07 Million | - | -18.22 Thousand |
| Inventory | 366.3 Thousand | 1.79 Million | -1.93 Million | 1.57 Million | - | - |
| Other working capital | 35 Thousand | -30 Thousand | -6338.00 | - | - | - |
| Cash at beginning of period | 122.63 Thousand | 402.59 Thousand | 415.48 Thousand | 386.52 Thousand | - | 272.57 Thousand |
| Cash at end of period | 56.2 Thousand | 122.63 Thousand | 402.59 Thousand | 415.48 Thousand | - | 270.58 Thousand |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 386.52 Thousand | - | - |
| Net cash flow / Change in cash | -66.43 Thousand | -279.95 Thousand | -12.88 Thousand | 28.96 Thousand | - | -1995.00 |
| Free Cash Flow | -298.82 Thousand | -508.95 Thousand | -2.26 Million | -171.04 Thousand | -72 Thousand | -548.79 Thousand |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.67 Million | 407.87 Thousand | -728.14 Thousand | 693.24 Thousand | 1.29 Million | -6.66 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 4.26 Million |
| Change in working capital | 715.42 Thousand | 146.08 Thousand | 738.53 Thousand | -816.49 Thousand | 647.29 Thousand | 1.74 Million |
| Other non-cash items | -3.36 Million | -678.28 Thousand | -761.23 Thousand | 737.4 Thousand | -2.66 Million | 2.63 Million |
| Investing Cash Flow | 200 Thousand | - | - | 200 Thousand | - | -135 Thousand |
| Investments in PPE | - | 2.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -270 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 135 Thousand |
| Other Investing Activities | 200 Thousand | - | - | 200 Thousand | - | -135 Thousand |
| Financing Cash Flow | 32.39 Thousand | 12.46 Thousand | 69.02 Thousand | -49.5 Thousand | 400.00 | 364 Thousand |
| Debt repayment | -63 Thousand | -12.46 Thousand | -69.02 Thousand | -49.5 Thousand | -95 Thousand | -6000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 95.4 Thousand | - | - | - | 95.4 Thousand | 370 Thousand |
| Other Financing Activities | - | - | - | - | - | 364 Thousand |
| Accounts receivables | 374.77 Thousand | 80.56 Thousand | -129.38 Thousand | - | 423.6 Thousand | -390.4 Thousand |
| Accounts payables | -60.65 Thousand | 80.73 Thousand | 192.37 Thousand | -737.41 Thousand | 403.64 Thousand | 374.39 Thousand |
| Inventory | 366.3 Thousand | -45.21 Thousand | 670.54 Thousand | -79.08 Thousand | -179.95 Thousand | 1.79 Million |
| Other working capital | 35 Thousand | 30 Thousand | 5000.00 | - | - | -30 Thousand |
| Cash at beginning of period | 122.63 Thousand | 51.97 Thousand | 253.00 | 52.09 Thousand | 122.63 Thousand | 402.59 Thousand |
| Cash at end of period | 56.2 Thousand | 56.2 Thousand | 51.97 Thousand | 253.00 | 52.09 Thousand | 122.63 Thousand |
| Capital Expenditure | - | 2.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -66.43 Thousand | 4233.00 | 51.72 Thousand | -51.84 Thousand | -70.54 Thousand | -279.95 Thousand |
| Free Cash Flow | -298.82 Thousand | -8230.00 | -17.3 Thousand | -202.34 Thousand | -70.94 Thousand | -508.95 Thousand |
7TEC
BVNNF
ARTEMISMED
IMPACT
5904
002378